Biotech

All Articles

James Wilson leaving behind Penn to launch two brand new biotechs

.After much more than three decades, genetics treatment trailblazer James Wilson M.D., Ph.D., is act...

3 biotechs make an effort to defeat the summer months heat through dropping team

.As biotechs attempt to transform a new webpage in August, at least 3 firms have actually shed staff...

venBio elevates $528M for 5th life scientific researches VC fund

.Veteran equity capital organization venBio has raised yet another half a billion dollars to purchas...

Otsuka pays for $800M for Jnana and its clinical-stage PKU medicine

.Otsuka Drug has picked up Boston-based Jnana Rehabs for $800 million so the Eastern biotech may obt...

FibroGen lays off 75% people team as possession fails 2 even more trials

.FibroGen is actually radically reorganizing its own organization, giving up 75% of its united state...

Tracon wane weeks after injectable PD-L1 prevention fall short

.Tracon Pharmaceuticals has decided to wane operations full weeks after an injectable immune checkpo...

Ideaya bags alternative on Biocytogen bispecific ADC in $400M offer

.Ideaya Biosciences is betting $400 million in biobucks that a bispecific antibody-drug conjugate (A...

Takeda takes $140M loss on stopped working epilepsy medication, boasts FDA run

.Our experts presently know that Takeda is actually intending to locate a road to the FDA for epilep...

VBI Injections files for insolvency, looks for asset sale

.Immunology biotech VBI Injections is diverting precariously near the defining moment, along with pl...

Celldex anti-cKIT antibody lessen hives in another phase 2 research study

.It's hard to muscle mass in on a room as competitive as immunology, but Celldex Rehabs believes tha...